65
Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Embed Size (px)

Citation preview

Page 1: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Laboratory MedicineInfectious Disease

Brenda Beckett, PA-C

Clinical Assessment II

Page 2: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Infectious Disease

Urinalysis Serum serologies (antibody testing)

– Hepatitis, others

Cultures: bacterial, viral Rapid antigen testing O&P Nosocomial infections CBC results with viral vs bacterial infection

Page 3: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Specimen Collection

Urinalysis - clean catch used if culture is needed.

Reflex testing - microscopic or culture if UA abnormal

Proper collection of cultures

Page 4: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Urinalysis Specimen type (clean catch, catheter,

suprapubic aspiration, U-bag (nonsterile) Gross analysis - color, clarity Dipstick Microscopic - cellular elements Culture if indicated: if infection is possible

from dipstick or microscopic results

Page 5: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Urinalysis

Color: Normal = straw, light yellow.– Amber/orange = bilirubin, urobilinogen– Red = blood– Other colors

Clarity: Normal = clear– Hazy– Cloudy

• Artifact or cellular elements

Page 6: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II
Page 7: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Urine Dipstick

Protein: Usually in form of albumin or globulins. – Trace amounts in DM associated with

increased mortality due to diabetic nephropathy.

– Globulins (Bence-Jones) associated with multiple myeloma

– Large amounts in nephrotic syndrome

Page 8: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Urine Dipstick

pH: Normal 5-9, usually around 6. Acidotic or alkalotic can be due to diet, medication, disease or metabolic changes. Some bacteria incr. pH

Specific Gravity: Normal 1.010-1.025. Weight of particles in solution, correlates with osmolality.

Page 9: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Urine Dipstick

Bilirubin: Increased in obstructive biliary disease, hepatocellular injury. Not incr in hemolytic jaundice.

Urobilinogen: Formed by bacterial conversion of conj. Bilirubin in intestine. Incr in hepatocellular injury and jaundice, not obstructive biliary disease. Also increased in CHF with liver congestion, cirrhosis, hepatitis.

Page 10: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Urine Dipstick

Blood: Detects blood & hemoglobin. Can cross react with myoglobin. Increased in hemolysis, GU tract

cancer, UTI, calculi, coagulopathies, glomerulonephritis.

Page 11: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Urine Dipstick

Glucose: Present if serum glucose is > 180 mg/dL. Increased in DM.

Ketones: Screening for ketoacidosis in diabetics. Increased in starvation, fever, pregnancy.

Page 12: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Urine Dipstick

Leukocyte Esterase: Enzyme released by WBCs. Marker of infection or inflammation

Nitrite: Urine nitrates are converted to nitrite by some bacteria (E. coli, Klebsiella, Proteus, etc.)

Page 13: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Microscopic

Done if dipstick abnormal Detects cellular elements

– WBC– RBC– Bacteria– Epithelial cells – if contaminated sample, or

tubules sloughing– Casts, crystals

Page 14: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Urine culture

Semi-quantitative >100,000 colonies/ml indicative of

infection >10,000 colonies/ml in

symptomatic,immunosuppressed or abx treated patients

Lower numbers suprapubic (>150)

Page 15: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Serology

Testing serum to determine antibody levels.

Used for many viruses and other infectious agents

IgM - early infection IgG - lifelong, immunity

Page 16: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Hepatitis - Causes

Drugs: antihypertensives, statins, antibiotics, others.

Toxic agents: acetaminophen, alcohol, others.

Viruses: Hepatitis A (HAV), B (HBV), C (HCV) commonly. Uncommon: EBV, CMV, measles, rubella, etc.

Page 17: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Liver Function Tests

Serum Aminotransferases (ALT and AST)

Serum and urine Bilirubin Serum Alkaline Phosphatase Additionally: LDH, GGTP, Albumin,

Prothrombin Time

Page 18: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Liver Function Tests

ALT – Alanine Aminotransferase AST – Aspartate Aminotransferase

– Inflammation and cell necrosis– Most sensitive marker of liver injury (from

infections, toxins, autoimmunity, etc)

Page 19: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Bilirubin

Hemoglobin breakdown product Conjugated by liver, excreted in bile,

eliminated in urine Bilirubin increased in:

– Biliary tract obstruction (tumor, stone, pancreatitis)

– Inflammation (hepatitis)– Hemolysis (Gilbert’s syndrome)

Page 20: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Bilirubin

Bilirubinuria occurs in both inflammation and obstruction (but not hemolysis)

Jaundice results when levels exceed 2.5 mg/dl

In viral hepatitis, bilirubin not always elevated, therefore:

Elevated serum bilirubin is neither sensitive nor specific for viral hepatitis

Page 21: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

More Liver Function Tests

Serum albumin: decreased in cirrhosis and severe, fulminant disease

Prothrombin time: Prolonged in severe liver disease (vitamin K deficiency)

LDH (lactate dehydrogenase): non specific, not very useful.

ALKP: sensitive marker of biliary tract obstruction, mildly elevated in viral hep.

Page 22: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Lab Findings

ALT usually >8x upper limit of normal ALT usually elevated >AST ALKP modestly elevated Bilirubin normal to highly elevated

– These are quick tests if you suspect hepatitis.

– If elevated, proceed to serology testing

Page 23: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Hepatitis A Serology

HAV IgM – rises early in illness, will remain positive for up to six months.

HAV IgG – will appear soon after IgM and remain elevated for years.

– Most common cause of acute viral hepatitis (AVH), no chronicity, no carrier state

Page 24: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II
Page 25: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Hepatitis A Serology

Testing for Hep A includes HAV Total (IgG and IgM), and HAV IgM. So,– If someone has a positive HAV Total and

an positive HAV IgM, they have a current infection.

– If someone has a positive Total and a negative IgM, they had a past infection or passive immunity (vaccination).

Page 26: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Hepatitis B

Second most common cause of acute viral hepatitis

Most complex hepatitis virus -infective particle made up of viral core plus an outer surface coat

5-10% become chronic, lead to cirrhosis, hepatocellular cancer

Page 27: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Hepatitis B Serology

HBsAg: First evidence of infection, persists through clinical illness.

Anti-HBs: Antibody to HBsAg appears after clearance of HBsAg and after vaccination (titer >=10 mU/mL).– Neg HBsAg and pos Anti-HBs means

recovery from HBV infection, noninfectivity and immunity.

Page 28: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Hepatitis B Serology

Anti-HBc: – IgM anti-HBc appears shortly after HBsAg.

Indicates acute hepatitis. Persists for 3-6 months or longer. May appear during flares of chronic HBV.

– IgG anti-HBc appears during acute HBV but persists indefinitely, whether recovery or chronic hepatitis occurs.

Page 29: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Hepatitis B Serology

HBeAg: A soluble protein found in HBsAg positive patients. Indicates viral replication and infectivity. Appearance beyond 3 months indicates increased likelihood of chronicity.

HBV DNA: Parallels presence of HBeAg, more sensitive and precise

Page 30: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Acute Hepatitis B Course

Page 31: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II
Page 32: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Hepatitis B Review

Acute HBV: HBsAg+, IgM anti-HBc+, Total anti-HBc+, anti-HBs-, HBeAg+.

Chronic HBV: HBsAg+, IgM anti-HBc-, Total anti-HBc+, anti-HBs-.

Past resolved HBV: HBsAg-, IgM anti-HBc-, Total anti-HBc+, anti-HBs+.

Vaccination (immunity): anti-HBs+.

Page 33: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Hepatitis C

Chronicity common (>70%) Prolonged viremia Aminotransferases elevated off and on (can

have ALT >7x normal) Diagnose with Anti-HCV EIA

– False negatives early in disease (low sensitivity)– False positives with elevated gamma glob (low

specificity)

Page 34: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Hepatitis C Serology

Positive Anti-HCV EIA needs confirmation

HCV RIBA (Recombinant Immunoblot Assay) confirms + EIA. Does not distinguish between past/present infection. Being replaced by HCV-RNA

Liver Biopsy

Page 35: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Hepatitis C Serology

HCV-RNA by RT-PCR. – Most sensitive test– Diagnose acute infection prior to

seroconversion– May be intermittent (neg does not mean no

disease)– Qualitative and quantitative tests– Response to therapy

Page 36: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II
Page 37: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II
Page 38: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Hepatitis C

NO immunization No post exposure prophylaxis Chronicity common Different genotypes respond differently

to therapy

Page 39: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Other Hepatitis Viruses

Hepatitis D (Delta). – Due to ssRNA virus. – Always associated with Hepatitis B. – Acute or chronic. – Often severe, high mortality.

Hepatitis E. Due to ssRNA virus. – Rare, occurs in endemic areas.

Page 40: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Chronic Hepatitis

HBV – 5-10% of acute infections HCV - >70% of acute infections HDV – with HBV coinfection or

superinfection

– Elevated aminotransferases for >6 months– My lead to cirrhosis, hepatocellular ca– Liver transplant may be indicated

Page 41: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Acute Viral Hepatitis Panel

HBsAg IgM anti-HBc Igm anti-HAV Anti-HCV EIA

Page 42: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Post Exposure Testing

Source Patient: – Anti-HIV – HBsAg – Anti-HCV EIA

Injured HCW: – Anti-HIV – Anti-HCV EIA – Anti-HBs

Page 43: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Review of Hepatitis Serology

http://www.cdc.gov/hepatitis/

Excellent website with graphic representation of each type of viral hepatitis, case studies (click on “Training Resources”, then “Viral Hepatitis Online Serology Training”)

Page 44: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

HIV testing

ELISA antibody (screening) Western Blot (confirmation) RNA PCR (viral load) CD4 count and %

Page 45: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

LYME Antibodies

Lyme ab. IgM and IgG, screening with ELISA testing. Confirm with WB

Poor sensitivity/specificity IgM – 2-4 wks post infection, decline by

4-6 months IgG – 4-8 wks post infection, high for

months or years Must correlate clinically

Page 46: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Antigen testing

Tests for the actual infectious agent Example: Some Hepatitis testing Rapid antigen tests: Rapid strep, Rapid

flu, C. diff, etc. Test for a protein or other marker on the bacteria or virus, not a full culture

Page 47: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Stool Testing

O&P, will determine if there are parasites present in feces. May need more than one sample, not always shedding.

Culture: tests for Salmonella, Shigella, Campylobacter, E.coli 0157

WBC, occult blood (Guiac) C. diff - rapid antigen test

Page 48: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Giardia

Page 49: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Viral Cultures

Viruses are slow to grow in culture medium, may take weeks for a result.

Therefore, serology is utilized more often.

May see herpes culture ordered to confirm outbreak.

Page 50: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Bacterial Cultures

Sterile vs nonsterile site Normal flora Aerobic vs anaerobic Gram stain is routinely performed on

cultures from certain sites: sputum, wound, CSF, etc.

Urine culture is semiquantiative others isolate bacterial colonies

Page 51: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Common SpecimensAbscess, pus, fluid –

swab or aspirate

Blood–special vacutainer

Body fluids –(amniotic, pericardial, peritoneal, pleural, synovial) – needle aspiration

CSF – lumbar puncture

Cutaneous-skin or nail scrapings, swab of infection

Ear- middle ear myringotomy, outer ear swab

Eye – swab conjunctiva, corneal scrapings

FB – IV cath tips, prosthetic heart valves, IUD, etc.

GI – Gastric biopsy for H. pylori, rectal swab, stool for O&P, culture

Genital – cervical, urethral, vaginal secretions or swab.

Resp – sputum, lavage, nasopharynx/pharynx swab

Tissue – biopsy

Urine – clean catch, cath, suprapubic aspirate

Page 52: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Bacterial Culture – Gram stain

Done quickly Only on certain sites Need to correlate with clinical picture Results will be verified by culture in 24-

48 hrs, but can start empirically on antibiotics

Report: Gram +/-, shape, other cellular elements (WBC, epithelials, etc)

Page 53: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Gram Stain: G+

Page 54: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Gram Stain: G-

Page 55: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Bacterial Cultures

Most streak for isolation Plated on specific media for site of

culture Grown in appropriate environment Will only be grown anaerobically if

requested

Page 56: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Streak for isolation

Page 57: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Urine culture

Page 58: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Bacterial Cultures

Sensitivities if bacteria is a pathogen Antibiotics tested vary from lab to lab,

depending on g+ or g- Certain species do not have sensitivities

performed. Ex: Strep, usually sens to penicillins so no sensitivities performed

Hospital antibiogram – common bacteria and their susceptibilities

Page 59: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Beta Hemolysis

Page 60: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Alpha, Beta Hemolysis

Page 61: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Blood Culture

Page 62: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Nosocomial Infections

Originate in hospitals Account for tens of thousands of deaths

per year 5-10% of hospitalized patients Due to:

– Prevalence of pathogens– Compromised hosts– Effective transmission

Page 63: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

Nosocomial Infections

Primary pathogens:– Enterococcus (VRE)– E. coli– Pseudomonas– Staph Aureus (MRSA)– C. diff

Acquire antibiotic resistance Become normal flora for hospital workers Common sites: urinary tract, wounds,

respiratory, skin, blood, GI

Page 64: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

CA MRSA

Community acquired MRSA Athletes, children, military recruits,

close living quarters Not hospitalized or in long-term care

Page 65: Laboratory Medicine Infectious Disease Brenda Beckett, PA-C Clinical Assessment II

WBC overview

Viral vs. bacterial infection– Viral: lymphocyte response (T, B or NK).

May have slightly elevated or suppressed total WBC count

– Bacterial: Neutrophil response with early forms (bands). Often higher total WBC

Sepsis– Neutropenia or neutrophilia, immature

forms